No Data
No Data
Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference
Molecular Partners and Orano Med Expand Partnership to Develop Targeted Alpha Radio-Therapies for Cancer
Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January
Reported Sunday, Molecular Partners Reports Initial Efficacy And Safety Data For MP0533 In Phase 1/2a Study And Preclinical Success Of MP0621 At ASH 2024
Express News | Molecular Partners AG : JP Morgan Cuts Target Price to $5.1 From $5.4
Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024
Buy n Die Together❤ :![](https://emoticon.moomoo.com/rich_big_face3_mm_v2/bf_124.png)
BAO BMW : master , which one is the lowest prices to pick? any advice
Cui Nyonya Kueh :![](https://emoticon.futunn.com/rich_daily_life/O_02.png)
Andy loving trading : Master MOLN can be Buy at the moment?
北美深蓝 Andy loving trading : $Molecular (MOLN.US)$Buyable. Buy with long-term funds. Super long position. Venture capital position, moderately heavy.